CIG Media Group Announces the Appointment of Stephen Close as Senior Manager, Advertising Sales
JUNE 30, 2009
CIG Media Group welcomes Stephen Close as the Senior Manager, Advertising Sales, for its portfolio of tumor-specific clinical oncology journals. Close joins CIG with more than 15 years of sales experience in the medical space, including five years in oncology. Most recently, Close worked at Elsevier as a National Account Manager, where he was responsible for ad sales for a collection of print and online publications from the American Association of Thoracic Surgery, the Society for Vascular Surgery, the American College of Surgeons, and the American Medical Directors Association.
Close began his career with SmithKline Beecham Pharmaceuticals as a detail representative. Subsequently, prior to his position at Elsevier, Steve was National Account Manager for Pharmaceutical Media, an independent representation firm, where he achieved consistent yearly ad sales growth for Oncology Times and assisted in the launch of Neurology Today.
“Steve’s background and experience are a perfect fit for CIG’s portfolio of clinical oncology journals. His professionalism and drive for excellence will serve our clients and our company well. Steve is the perfect sales professional to demonstrate to our clients how CIG journals can help them reach their audience of prescribing physicians and raise awareness and improve accruals for their clinical trials,” says Jasper Simons, Vice President and Publisher at CIG Media Group.
Close graduated Sigma Tau from Kutztown University with a Bachelor of Arts in English. He officially started with CIG Media Group on June 29, 2009. Steve is based in Scotch Plains, New Jersey.
Contact: Steve Close
Sr. Manger, Advertising Sales
214.733-9342 phone
214.367.3301 fax
About CIG Media Group, LP
Dallas-based CIG Media Group, LP, is a subsidiary of Medical Media Holdings, LLC. Founded in 1996, CIG Media Group, LP, is the premier publisher of five peer-reviewed, tumor-specific medical oncology journals: Clinical Lung Cancer, Clinical Colorectal Cancer, Clinical Breast Cancer, Clinical Lymphoma & Myeloma, and Clinical Ovarian Cancer. All of the company’s established journals are indexed in PubMed. Each year, CIG Media Group, LP, also publishes multiple tumor-specific journal supplements that provide oncology professionals with opportunities to earn American Medical Association–accredited continuing medical education credits. For more information about CIG Media Group, LP, and its clinical oncology journals, please visit
www.cigjournals.com.
